P53 contributes to quercetin-induced apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes

Inflammation

Volumn 36, Issue 2, 2013, Pages 272-278

  Xiao, Peng ^a   Hao, Yingjie ^a   Zhu, Xu ^a   Wu, Xuejian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

apoptosis; mitochondrial membrane potential; p53; quercetin; rheumatoid arthritis fibroblast like synoviocytes (RAFLSs)

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; QUERCETIN;

APOPTOSIS; ARTICLE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; WESTERN BLOTTING;

ANTIOXIDANTS; APOPTOSIS; ARTHRITIS, RHEUMATOID; BCL-2-ASSOCIATED X PROTEIN; BENZOTHIAZOLES; CASPASE 3; CASPASE 9; CELLS, CULTURED; CYTOCHROMES C; DNA FRAGMENTATION; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; QUERCETIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84879505858     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9543-5     Document Type: Article

References (28)

1. Harris Jr.; E.D.; and Rheumatoid arthritis. 1990. Pathophysiology and implications for therapy. The New England Journal of Medicine 322: 1277-1289.
2. Tran, C.N.; S.K. Lundy, and D.A. Fox. 2005. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 12: 183-189.
3. Firestein, G.S. 2005. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. Journal of Clinical Rheumatology 11: S39-S44.
4. Gay, S.; R.E. Gay, and W.J. Koopman. 1993. Molecular and cellular mechanisms or joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Annals of the Rheumatic Diseases 52: S39-S47.
5. Huber, L.C.; O. Distler, I. Tamer, R.E. Gay, S. Gay, and T. Pap. 2006. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 45: 669-675.
6. Pattacini, L.; L. Boiardi, B. Casali, and C. Salvarani. 2010. Differential effects of anti-TNF-alpha drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford, England) 49: 480-489.
7. Miyashita, T.; A. Kawakami, M. Tamai, Y. Izumi, H. Mingguo, F. Tanaka, S. Abiru, K. Nakashima, N. Iwanaga, K. Aratake, M. Kamachi, K. Arima, H. Ida, K. Migita, T. Origuchi, S. Tagashira, F. Nishikaku, and K. Eguchi. 2003. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells. Biochemical and Biophysical Research Communications 312: 397-404.
8. Palao, G.; B. Santiago, M. Galindo, M. Pallá, J.C. Ramírez, and J.L. Pablos. 2004. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis and Rheumatism 50: 2803-2810.
9. Aupperle, K.R.; D.L. Boyle, M. Hendrix, E.A. Seftor, N.J. Zvaifler, M. Barbosa, and G.S. Firestein. 1998. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. The American Journal of Pathology 152: 1091-1098.
10. Chou, C.T.; J.S. Yang, and M.R. Lee. 2001. Apoptosis in rheumatoid arthritis - expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. The Journal of Pathology 193: 110-116.
11. Bae, S.C.; W.J. Jung, E.J. Lee, R. Yu, and M.K. Sung. 2009. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. Journal of the American College of Nutrition 28: 56-62.
12. Jackson, J.K.; T. Higo, W.L. Hunter, and H.M. Burt. 2006. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflammation Research 55: 168-175.
13. Sato, M.; T. Miyazaki, F. Kambe, K. Maeda, and H. Seo. 1997. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. The Journal of Rheumatology 24: 1680-1684.
14. Choi, E.J.; S.C. Bae, R. Yu, J. Youn, and M.K. Sung. 2009. Dietary vitamin E and quercetin modulate inflammatory responses of collagen-induced arthritis in mice. Journal of Medicinal Food 12: 770-775.
15. Sung, M.S.; E.G. Lee, H.S. Jeon, H.J. Chae, S.J. Park, Y.C. Lee, and W.H. Yoo. 2012. Quercetin inhibits IL-1β-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast. Inflammation 35: 1585-1594.
16. Ong, C.S.; E. Tran, T.T. Nguyen, C.K. Ong, S.K. Lee, J.J. Lee, C.P. Ng, C. Leong, and H. Huynh. 2004. Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncology Reports 11: 727-733.
17. Arnett, F.C.; S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315-324.
18. Brunelle, J.K.; and A. Letai. 2009. Control of mitochondrial apoptosis by the Bcl-2 family. Journal of Cell Science 122: 437-441.
19. Vaseva, A.V.; and U.M. Moll. 2009. The mitochondrial p53 pathway. Biochimica et Biophysica Acta 1787: 414-420.
20. Zhao, H.; F. Traganos, and Z. Darzynkiewicz. 2008. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation. Cell Cycle 7: 3048-3055.
21. Natarajan, V.; N. Krithica, B. Madhan, and P.K. Sehgal. 2011. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. Journal of Pharmaceutical Sciences 100: 195-205.
22. Choi, J.A.; J.Y. Kim, J.Y. Lee, C.M. Kang, H.J. Kwon, Y.D. Yoo, T.W. Kim, Y.S. Lee, and S.J. Lee. 2001. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. International Journal of Oncology 19: 837-844.
23. Lee, T.J.; O.H. Kim, Y.H. Kim, J.H. Lim, S. Kim, J.W. Park, and T.K. Kwon. 2006. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Letters 240: 234-242.
24. Jacquemin, G.; V. Granci, A.S. Gallouet, N. Lalaoui, A. Morlé, E. Iessi, A. Morizot, C. Garrido, T. Guillaudeux, and O. Micheau. 2012. Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells. Haematologica 97: 38-46.
25. Firestein, G.S.; K. Nguyen, K.R. Aupperle, M. Yeo, D.L. Boyle, and N.J. Zvaifler. 1996. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. The American Journal of Pathology 149: 2143-2151.
26. Redondo, A.; N. Estrella, A.G. Lorenzo, M. Cruzado, and C. Castro. 2012. Quercetin and catechin synergistically inhibit angiotensin II-induced redox-dependent signalling pathways in vascular smooth muscle cells from hypertensive rats. Free Radical Research 46: 619-627.
27. Hwang, S.J.; B. Choi, S.S. Kang, J.H. Chang, Y.G. Kim, Y.H. Chung, D.H. Sohn, M.W. So, C.K. Lee, W.H. Robinson, and E.J. Chang. 2012. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Research & Therapy 14: R14.
28. Lau, S.T.; Z.X. Lin, and P.S. Leung. 2010. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. British Journal of Cancer 102: 583-593.